[…]
Arthritis News
FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis
[…]
High Disease Activity During Pregnancy Associated with Lower Birth Weight
[…]
Surveillance Study Reports No Increase in Cancer Risk Over First Six years of TNF Inhibitor Use
While most observational studies have not demonstrated an increase in malignancy independently associated with TNF inhibitor use, a meta-analysis of short-term clinical trials data suggested an increase in malignancy risk occurring within months of initiating therapy with monoclonal antibodies directed against TNF-α (infliximab and adalimumab).
Study Explores the Prevalence of Psoriatic Arthritis Among Individuals with Psoriasis
Estimates of the prevalence of psoriatic arthritis among individuals with skin psoriasis have varied in the literature from between 2% to more than 40%, depending on the method of ascertainment and case definition used to define psoriatic arthritis.
Large Study of Acute Back Pain Demonstrates Rarity of Serious Pathology
[…]
